Resveratrol inhibits neointimal formation after arterial injury through an endothelial nitric oxide synthase-dependent mechanism.
about
Non-Nutrient, Naturally Occurring Phenolic Compounds with Antioxidant Activity for the Prevention and Treatment of Periodontal DiseasesExperimental studies of the molecular pathways regulated by exercise and resveratrol in heart, skeletal muscle and the vasculatureHigh-throughput screening identifies idarubicin as a preferential inhibitor of smooth muscle versus endothelial cell proliferationResveratrol-Induced Vascular Progenitor Differentiation towards Endothelial Lineage via MiR-21/Akt/β-Catenin Is Protective in Vessel Graft ModelsMatrix metalloproteinases in atherosclerosis: role of nitric oxide, hydrogen sulfide, homocysteine, and polymorphisms.SIRT1, p66(Shc), and Set7/9 in vascular hyperglycemic memory: bringing all the strands togetherBaseline elevated Lp-PLA2 is associated with increased risk for re-stenosis after stent placement.Resveratrol Treatment Normalizes the Endothelial Function and Blood Pressure in Ovariectomized Rats.Skewed Epigenetics: An Alternative Therapeutic Option for Diabetes Complications.Therapeutic potential of resveratrol in heart failure.An update on the role of nutrigenomic modulations in mediating the cardiovascular protective effect of fruit polyphenols.Role of parnaparin in atherosclerosis.Resveratrol decreases periodontal breakdown and modulates local levels of cytokines during periodontitis in rats.Drug Distribution and Basic Pharmacology of Paclitaxel/Resveratrol-Coated Balloon CathetersThe polyphenol resveratrol promotes skeletal growth in mice through a sirtuin 1-bone morphogenic protein 2 longevity axis
P2860
Q26771202-34CC77B9-CBD1-4D9B-A397-14EED1356F18Q27016095-CFCFCAAE-B462-42F4-9B14-83C5C22939B3Q28540089-7E3EC5E5-A583-46FF-A46B-73CD80806033Q28910228-75DB1AD4-C931-473F-9F08-AD0E17DBD082Q35161646-BDE789B1-F68E-4CFC-9426-F08E30089765Q36867464-07118877-38A1-4190-9E9D-92E28A893BF0Q37685077-4B8E8192-8E57-4960-8B1E-14DCB1B111C6Q37691728-AC4D94C9-797D-437B-B7DA-EE9BC79CFB7AQ38524836-18AF5734-B52F-44BC-AF2E-92C8105C3149Q38552981-CE5B624A-5866-4FD7-B8C6-BAB06A5F5547Q38930965-7A864B29-4BC0-4614-89DA-5F8FA75FBF11Q38958355-99C8D117-3BC4-4CF1-998C-65F774CF57B0Q39451993-F5DF7292-4AF3-47A0-8EE1-646CF30BFF4DQ56964102-C60BD7B5-7609-4199-8969-048E84E3C78EQ58721800-7DF68F93-7DEA-4671-86C6-BDFFB2315652
P2860
Resveratrol inhibits neointimal formation after arterial injury through an endothelial nitric oxide synthase-dependent mechanism.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Resveratrol inhibits neointima ...... synthase-dependent mechanism.
@en
Resveratrol inhibits neointima ...... synthase-dependent mechanism.
@nl
type
label
Resveratrol inhibits neointima ...... synthase-dependent mechanism.
@en
Resveratrol inhibits neointima ...... synthase-dependent mechanism.
@nl
prefLabel
Resveratrol inhibits neointima ...... synthase-dependent mechanism.
@en
Resveratrol inhibits neointima ...... synthase-dependent mechanism.
@nl
P2093
P1433
P1476
Resveratrol inhibits neointima ...... synthase-dependent mechanism.
@en
P2093
Danna M Breen
Evangelia L Tsiani
Hangjun Zhang
Husam Ghanim
Jason R B Dyck
Margaret Mroziewicz
Michelle P Bendeck
Paresh Dandona
Scott P Heximer
P304
P356
10.1016/J.ATHEROSCLEROSIS.2012.03.021
P50
P577
2012-03-27T00:00:00Z